Tri-heart Plus

Tri-heart Plus Manufacturers

• Intervet, Inc. A Subsidiary Of Merck And Company, Inc.
  

  ×

  Tri-heart Plus | Intervet, Inc. A Subsidiary Of Merck And Company, Inc.

  

  ---

  DOSAGE: Tri-Heart® Plus ivermectin/pyrantel chewable tablets should be administered orally at monthly intervals at the
  recommended minimum dose level of 6 mcg of ivermectin per kilogram (2.72 mcg/lb) and 5 mg of pyrantel (as
  pamoate salt) per kg (2.27 mg/Ib) of body weight. The recommended dosing schedule for prevention of canine
  heartworm disease and for the treatment and control of ascarids and hookworms is as follows:

  Dog Weight
  Chewable Tablets
  per Month Ivermectin
  Content Pyrantel
  Content Color Coding on
  Blister Card and Carton Up  to 25 lbs. 1 68 mcg 57 mg Blue 26 to 50 lbs. 1 136 mcg 114 mg Green 51 to 100 lbs. 1 272 mcg 227 mg Brown

  Tri-Heart® Plus ivermectin/pyrantel chewable tablets are recommended for dogs 6 weeks of
  age and older. For dogs over 100 lbs, use the appropriate combination of these tablets.
  
  ADMINISTRATION: Remove only one chewable tablet at a time from the blister card.
  Because most dogs find Tri-Heart®t Plus chewable tablets palatable, the product can be
  offered to the dog by hand. Alternatively, it may be added intact to a small amount of dry food
  or placed in the back of the dog’s mouth for forced swallowing.
  
  Care should be taken that the dog consumes the complete dose, and treated animals should
  be observed for a few minutes after administration to ensure that part of the dose is not lost
  or rejected. If it is suspected that any of the dose has been lost, redosing is recommended.
  
  Tri-Heart® Plus chewable tablets should be given at monthly intervals during the period of the
  year when mosquitoes (vectors), potentially carrying infective heartworm larvae, are active.
  The initial dose must be given within a month (30 days) after the dog’s first exposure to mosquitoes.
  The final dose must be given within a month (30 days) after the dog’s last exposure
  to mosquitoes.
  
  When replacing another heartworm preventive product in a heartworm disease preventive
  program, the first dose of Tri-Heart® Plus chewable tablets must be given within a month (30
  days) of the last dose of the former medication.
  
  If the interval between doses exceeds a month (30 days), the efficacy of ivermectin can be
  reduced. Therefore, for optimal performance, the chewable tablet must be given once a
  month on or about the same day of the month. If treatment is delayed, whether by a few days
  or many, immediate treatment with Tri-Heart® Plus chewable tablets and resumption of the
  recommended dosing regimen minimizes the opportunity for the development of adult
  heartworms.
  
  Monthly treatment with Tri-Heart® Plus chewable tablets also provides effective treatment
  and control of ascarids (T. canis, T. leonina) and hookworms (A. caninum, U. stenocephala,
  A. braziliense). Clients should be advised of measures to be taken to prevent reinfection with
  intestinal parasites.
  

  Close
  No Recall

  More Info